ARCHIVES

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 21 | May 24, 2002

Download PDF Visit The Full Archive

Related Articles

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

May 20, 2005

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

Blumenthal Names Presidential Advisor; Groups Lobby To Limit Her Influence

October 3, 1997

PDQ Used Mainly For Information To Public, Not Much By Non-Oncologists, Evaluation Finds

August 18, 1989

Local University Competing for Part FCRF Contract

December 4, 1981

Senate Appropriations Committee Earmarks $118 Million for Centers, Orders Full Grant Funding

October 9, 1987